Pre-operative anaemia

Anaesthesia

Volumn 70, Issue , 2015, Pages 20-28

  Clevenger, B ^a   Richards, T ^b,c  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON;

ANEMIA; BLOOD; BLOOD TRANSFUSION; CHRONIC KIDNEY FAILURE; DEFICIENCY; HUMAN; PREOPERATIVE PERIOD; PREVALENCE;

ANEMIA; BLOOD TRANSFUSION; FERRITINS; HUMANS; IRON; PREOPERATIVE PERIOD; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC;

EID: 84925222422     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/ANAE.12918     Document Type: Review

References (82)

1. Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 2010; 113: 482–95.
2. Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in non-cardiac sur-gery: a retrospective cohort study. Lancet 2011; 378: 1396– 407.
3. Ferraris VA, Davenport DL, Saha SP, Austin PC, Zwischenberger JB. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Archives of Surgery 2012; 147: 49–55.
4. JPAC – Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee. Patient Blood Management, 2014. www.transfusionguidelines. org.uk/uk-transfusion-committees/national-blood-transfusion-committee/patient-blood-management (accessed 13/08/2014).
5. Gombotz H, Rehak PH, Shander A, Hofmann A. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007; 47: 1468–80.
6. Gombotz H, Rehak PH, Shander A, Hofmann A. The second Austrian benchmark study for blood use in elective surgery: results and practice change. Transfusion 2014; 54: 2646–57.
7. World Health Organization. Nutritional Anaemias: Report of a WHO Scientific Group [Meeting held in Geneva from 13 to 17 March 1967]. Geneva: World Health Organization, 1968.
8. Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood 2014; 123: 615–24.
9. Guralnik JM. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unex-plained anemia. Blood 2004; 104: 2263–8.
10. Partridge J, Harari D, Gossage J, Dhesi J. Anaemia in the older surgical patient: a review of prevalence, causes, implications and management. Journal of the Royal Society of Medicine 2013; 106: 269–77.
11. Kengne AP, Czernichow S, Hamer M, Batty GD, Stamatakis E. Anaemia, haemoglobin level and cause-specific mortality in people with and without diabetes. PLoS ONE 2012; 7: e41875.
12. Shander A, Goodnough LT, Javidroozi M, et al. Iron deficiency anemia – bridging the knowledge and practice gap. Transfusion Medicine Reviews 2014; 28: 156–66.
13. Shander A, Knight K, Thurer R, Adamson J, Spence R. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. American Journal of Medicine 2004; 116: 58–69.
14. Baron DM, Hochrieser H, Posch M, et al. Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. British Journal of Anaesthesia 2014; 113: 416–23.
15. Goodnough LT, Levy JH, Murphy MF. Concepts of blood transfusion in adults. Lancet 2013; 381: 1845–54.
16. Weiskopf RB, Viele MK, Feiner J, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. Journal of the American Medical Association 1998; 279: 217– 21.
17. Geisel T, Martin J, Schulze B, et al. An etiologic profile of anemia in 405 geriatric patients. Anemia 2014; 2014, Article ID 932486.
18. Hung M, Besser M, Sharples LD, Nair SK, Klein AA. The prevalence and association with transfusion, intensive care unit stay and mortality of pre-operative anaemia in a cohort of cardiac surgery patients. Anaesthesia 2011; 66: 812–8.
19. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2007; 116: e418–500.
20. Peerless JR, Alexander JJ, Pinchak AC, Piotrowski JJ, Malangoni MA. Oxygen delivery is an important predictor of outcome in patients with ruptured abdominal aortic aneurysms. Annals of Surgery 1998; 227: 726–32.
21. Snowden CP, Prentis JM, Anderson HL, et al. Submaximal cardiopulmonary exercise testing predicts complications and hospital length of stay in patients undergoing major elective surgery. Annals of Surgery 2010; 251: 535–41.
22. Older P, Hall A, Hader R. Cardiopulmonary exercise testing as a screening test for perioperative management of major surgery in the elderly. Chest 1999; 116: 355–62.
23. Levine BD. VO2max: what do we know, and what do we still need to know? Journal of Physiology 2007; 586: 25–34.
24. Otto JM, O’Doherty AF, Hennis PJ, et al. Association between preoperative haemoglobin concentration and cardiopulmonary exercise variables: a multicentre study. Perioperative Medicine 2013; 2: 18.
25. Calbet JAL, Lundby C, Koskolou M, Boushel R. Importance of hemoglobin concentration to exercise: acute manipulations. Respiratory Physiology and Neurobiology 2006; 151: 132–40.
26. Otto JM, Montgomery HE, Richards T. Haemoglobin concentration and mass as determinants of exercise performance and of surgical outcome. Extreme Physiology and Medicine 2013; 2: 33.
27. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfu-sion. Cochrane Database Systematic Reviews 2012; 4: CD002042.
28. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, random-ized, controlled clinical trial of transfusion requirements in critical care. New England Journal of Medicine 1999; 340: 409–17.
29. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. New England Journal of Medicine 2011; 365: 2453–62.
30. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. New England Journal of Medicine 2013; 368: 11–21.
31. Wians FH, Urban JE, Keffer JH, Kroft SH. Discriminating between iron deficiency anemia and anemia of chronic disease using traditional indices of iron status vs transferrin receptor concentration. American Journal of Clinical Pathology 2001; 115: 112–8.
32. Weiss G, Goodnough LT. Anemia of chronic disease. New England Journal of Medicine 2005; 352: 1011–23.
33. Busti F, Campostrini N, Martinelli N, Girelli D. Iron deficiency in the elderly population, revisited in the hepcidin era. Frontiers in Pharmacology 2014; 5: 83.
34. Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxymal-tose in patients with heart failure and iron deficiency. New England Journal of Medicine 2009; 361: 2436–48.
35. Hsu C-Y, McCulloch CE, Curhan GC. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. Journal of the American Society of Nephrology 2002; 13: 504–10.
36. Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011; 117: 4425–33.
37. National Institute for Health and Care Excellence. Anaemia – iron deficiency; Clinical Knowledge Summary, 2013. cks.nice.org. uk/anaemia-iron-deficiency#!topicsummary (accessed 13/08/ 2014).
38. National Clinical Guideline Centre (UK). Anaemia Management in Chronic Kidney Disease: Rapid Update 2011. London: Royal College of Physicians (UK), 2011.
39. Thomas DW, Hinchliffe RF, Briggs C, et al. Guideline for the laboratory diagnosis of functional iron deficiency. British Journal of Haematology 2013; 161: 639–48.
40. Goddard AF, James MW, McIntyre AS, Scott BB, on behalf of the British Society of Gastroenterology. Guidelines for the management of iron deficiency anaemia. Gut 2011; 60: 1309–16.
41. National Institute for Clinical Excellence. CG3 – Preoperative Tests: The use of routine preoperative tests for elective sur-gery, 2003. www.nice.org.uk/guidance/cg3 (accessed 13/08/ 2014).
42. Goodnough LT, Maniatis A, Earnshaw P, et al. Detection, evalu-ation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. British Journal of Anaesthesia 2010; 106: 13–22.
43. Hung M, Ortmann E, Besser M, et al. A prospective observational cohort study to identify the causes of anaemia and association with outcome in cardiac surgical patients. Heart 2014; 89: 7–12.
44. Gurusamy KS, Nagendran M, Broadhurst JF, Anker SD, Richards T. Iron therapy in anaemic adults without chronic kidney dis-ease. Cochrane Database of Systematic Reviews 2013; 7: CD010640. doi: 10.1002/14651858.CD010640.
45. Nangaku M, Eckardt K-U. Pathogenesis of renal nemia. Seminars in Nephrology 2006; 26: 261–8.
46. McClellan W, Aronoff SL, Bolton WK, et al. The prevalence of anemia in patients with chronic kidney disease. Current Medical Research and Opinion 2004; 20: 1501–10.
47. Macdougall IC, Bock AH, Carrera F, et al. FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Nephrology, Dialysis and Transplantation 2014; 2014 Jun 6; doi 10.1093/ndt/gfu201.
48. Theusinger OM, Madjdpour C, Spahn DR. Resuscitation and transfusion management in trauma patients. Current Opinion in Critical Care 2012; 18: 661–70.
49. Cuenca J, Garcˇa-Erce JA, Munoz M, Izuel M, Martˇnez AA, Her-rera A. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. Transfusion 2004; 44: 1447–52.
50. Serrano-Trenas JA, Ugalde PF, Cabello LM, Chofles LC, Lazaro PS, Benˇtez PC. Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. Transfusion 2011; 51: 97–104.
51. Kim YH, Chung HH, Kang S-B, Kim SC, Kim YT. Safety and use-fulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study. Acta Haemato-logica 2009; 121: 37–41.
52. Auerbach M, Goodnough LT, Shander A. Iron: the new advances in therapy. Best Practice and Research Clinical Ana-esthesiology 2013; 27: 131–40.
53. Lin DM, Lin ES, Tran M-H. Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfusion Medicine Reviews 2013; 27: 221–34.
54. Evstatiev R, Marteau P, Iqbal T, et al. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 2011; 141: 846–53.e2.
55. Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfu-sion: systematic review and meta-analysis of randomised clinical trials. British Medical Journal 2013; 347: f4822.
56. Ponka P, Sheftel AD. Erythroid Iron Metabolism. Totowa, NJ: Humana Press, 2011: 191–209.
57. Richards T. PREVENTT (Preoperative intravenous iron to treat anaemia in major surgery) Protocol, 2013. preventt.lshtm.ac. uk/files/2014/06/PREVENTT-protocol_version-4_2013-Dec-16_ signed.pdf (accessed 13/08/2014).
58. Devon KM, McLeod RS. Pre and peri-operative erythropoietin for reducing allogeneic blood transfusions in colorectal cancer surgery. Cochrane Database of Systematic Reviews 2009; 1: CD007148.
59. Laupacis A, Fergusson DF. Erythropoietin to minimize perioper-ative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Transfusion Medicine 1998; 8: 309–17.
60. Alghamdi AA, Albanna MJ, Guru V, Brister SJ. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis. Journal of Cardiac Surgery 2006; 21: 320–6.
61. Unger EF, Thompson AM, Blank MJ, Temple R. Erythropoiesis-stimulating agents – time for a reevaluation. New England Journal of Medicine 2010; 362: 189–92.
62. Pascual M, Bohle B, Alonso S, et al. Preoperative administration of erythropoietin stimulates tumor recurrence after surgical excision of colon cancer in mice by a vascular endothelial growth factor. Journal of Surgical Research 2013; 183: 270–7.
63. Hetzel D, Strauss W, Bernard K, Li Z, Urboniene A, Allen LF. A Phase III, randomized, open-label trial of ferumoxytol com-pared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. American Journal of Hematology 2014; 89: 646–50.
64. Vadhan-Raj S, Strauss W, Ford D, et al. Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previ-ously unresponsive to or unable to tolerate oral iron. American Journal of Hematology 2013; 89: 7–12.
65. Auerbach M, Silberstein PT, Webb RT, et al. Darbepoetin alfa 300 or 500 lg once every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia. American Journal of Hematology 2010; 85: 655–63.
66. Bastit L, Vandebroek A, Altintas S, et al. Randomized, multi-center, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia. Journal of Clinical Oncology 2008; 26: 1611–8.
67. Steensma DP, Sloan JA, Dakhil SR, et al. Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoe-tin alfa for patients with chemotherapy-associated anemia. Journal of Clinical Oncology 2011; 29: 97–105.
68. Dangsuwan P, Manchana T. Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving che-motherapy. Gynecologic Oncology 2010; 116: 522–5.
69. Maccio A, Madeddu C, Gramignano G, Mulas C, Sanna E, Mantovani G. Efficacy and safety of oral lactoferrin supple-mentation in combination with rHuEPO-beta for the treatment of anemia in advanced cancer patients undergoing chemo-therapy: open-label, randomized controlled study. Oncologist 2010; 15: 894–902.
70. Hedenus M, Birgegard G, Nasman P, et al. Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study. Leukemia 2007; 21: 627–32.
71. Lindgren S, Wikman O, Befrits R, et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study. Scandinavian Journal of Gastroenterology 2009; 44: 838–45.
72. Beck-da-Silva L, Piardi D, Soder S, et al. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. International Journal of Cardiology 2013; 168: 3439–3442.
73. Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleed-ing: a randomized, controlled trial. Transfusion 2009; 49: 2719–28.
74. Abrahamsen AF. The effect of orally and parenterally administered iron in posthaemorrhagic anaemia. Acta Medica Scandi-navica 1965; 177: 503–7.
75. Edwards TJ, Noble EJ, Durran A, Mellor N, Hosie KB. Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery. The British Journal of Surgery 2009; 96: 1122–8.
76. Lidder PG, Sanders G, Whitehead E, et al. Pre-operative oral iron supplementation reduces blood transfusion in colorectal surgery – A prospective, randomised, controlled trial. Annals of the Royal College of Surgeons of England 2007; 89: 418–21.
77. Parker MJ. Iron supplementation for anemia after hip fracture surgery: a randomized trial of 300 patients. Journal of Bone and Joint Surgery 2010; 2: 265–9.
78. Sutton PM, Cresswell T, Livesey JP, Speed K, Bagga T. Treatment of anaemia after joint replacement. A double-blind, randomised, controlled trial of ferrous sulphate versus pla-cebo. Journal of Bone and Joint Surgery 2004; 1: 31–3.
79. Karkouti K, McCluskey SA, Ghannam M, Salpeter MJ, Quirt I, Yau TM. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Canadian Journal of Anesthesia 2006; 53: 11–9.
80. Madi-Jebara SN, Sleilaty GS, Achouh PE, et al. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia 2004; 18: 59–63.
81. Pieracci FM, Henderson P, Rodney JR, et al. Randomized, dou-ble-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. Surgical infections 2009; 10: 9–19.
82. European Medicines Agency. New recommendations to manage risk of allergic reactions with intravenous iron-containing medicines, 2013. www.ema.europa.eu/docs/en_GB/document_ library/Press_release/2013/06/WC500144874.pdf (accessed 13/08/2014).